ATE539082T1 - Oxazinylisoflavonoidverbindungen, medikamente und anwendungen - Google Patents

Oxazinylisoflavonoidverbindungen, medikamente und anwendungen

Info

Publication number
ATE539082T1
ATE539082T1 AT08714321T AT08714321T ATE539082T1 AT E539082 T1 ATE539082 T1 AT E539082T1 AT 08714321 T AT08714321 T AT 08714321T AT 08714321 T AT08714321 T AT 08714321T AT E539082 T1 ATE539082 T1 AT E539082T1
Authority
AT
Austria
Prior art keywords
compounds
oxazinylisoflavonoid
medications
cardioprotective
oxidant
Prior art date
Application number
AT08714321T
Other languages
English (en)
Inventor
Andrew Heaton
Naresh Kumar
Catherine Walker
Original Assignee
Novogen Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007901105A external-priority patent/AU2007901105A0/en
Application filed by Novogen Res Pty Ltd filed Critical Novogen Res Pty Ltd
Application granted granted Critical
Publication of ATE539082T1 publication Critical patent/ATE539082T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
AT08714321T 2007-03-02 2008-02-29 Oxazinylisoflavonoidverbindungen, medikamente und anwendungen ATE539082T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2007901105A AU2007901105A0 (en) 2007-03-02 Oxazinyl isoflavonoid compounds, medicaments and use
AU2007904434A AU2007904434A0 (en) 2007-08-17 Oxazinyl isoflavonoid compounds, medicaments and use
PCT/AU2008/000267 WO2008106715A1 (en) 2007-03-02 2008-02-29 Oxazinyl isoflavonoid compounds, medicaments and use

Publications (1)

Publication Number Publication Date
ATE539082T1 true ATE539082T1 (de) 2012-01-15

Family

ID=39737679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08714321T ATE539082T1 (de) 2007-03-02 2008-02-29 Oxazinylisoflavonoidverbindungen, medikamente und anwendungen

Country Status (7)

Country Link
US (1) US8367659B2 (de)
EP (1) EP2125831B1 (de)
JP (1) JP2010520156A (de)
AT (1) ATE539082T1 (de)
AU (1) AU2008222586A1 (de)
CA (1) CA2679580A1 (de)
WO (1) WO2008106715A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2324003A4 (de) * 2008-07-30 2011-11-16 Novogen Res Pty Ltd 6-substituierte isoflavonoide verbindungen und ihre verwendung
EP2362773A4 (de) * 2008-10-22 2012-05-09 Novogen Res Pty Ltd Verfahren zur auslösung von programmiertem zelltod
CN102924475B (zh) * 2009-02-09 2014-10-29 沈阳药科大学 新噁嗪类化合物及其抗血小板聚集的用途
CN102924476A (zh) * 2009-02-09 2013-02-13 沈阳药科大学 新噁嗪类化合物及其用途
WO2011066606A1 (en) * 2009-12-01 2011-06-09 Novogen Research Pty Ltd Pyranoindole compounds and uses thereof
CN101948475B (zh) * 2010-08-10 2014-06-25 沈阳药科大学 异黄酮衍生物-色烯(满)并噁嗪类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131193C (de) * 1965-01-28

Also Published As

Publication number Publication date
EP2125831A4 (de) 2010-05-05
EP2125831A1 (de) 2009-12-02
US8367659B2 (en) 2013-02-05
AU2008222586A1 (en) 2008-09-12
JP2010520156A (ja) 2010-06-10
WO2008106715A1 (en) 2008-09-12
EP2125831B1 (de) 2011-12-28
CA2679580A1 (en) 2008-09-12
US20110046722A1 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
MY153915A (en) Organic compounds
ATE528989T1 (de) Kristalline feste rasagilin-base
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
GEP20156230B (en) Forms of rifaximin and usage thereof
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
CL2009000426A1 (es) Compuestos derivados de carbociclil/heterociclil-piridin-2-il-urea, inhibidores de topoisomerasa iv bacteriana; composicion farmaceutica; y su uso para el tratamiento de infecciones bacterianas
JO3408B1 (ar) مركبات بترين سلفون اميد ثيازول و أوكسازول
CY1110813T1 (el) Χημικες ενωσεις
NO20082413L (no) Mikrobiocidal sammensetning
NO20090295L (no) Substituerte heteroarylderivater
NO20083630L (no) Nye pyridinderivater
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
JO2778B1 (en) Certain Compounds, Compositions and Methods
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
CL2007002890A1 (es) Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad.
CL2008002162A1 (es) Compuestos derivados de 3-benzoisoxazol-piperidin; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento y/o prevencion de trastornos cognitivos, adiccion a drogas, depresion, ansiedad, entre otras.
CL2009000281A1 (es) Compuestos derivados de 5,6-dihidro-pirrolo-[2,1-a]-isoquinolinas y pirrolo-[2,1-a]-isoquinolinas; composicion farmaceutica que comprende a dichos compuestos; y uso para el tratamaiento de trastornos de la fertilidad.
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
EA201000258A1 (ru) Новые гербициды
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
TW200738627A (en) Trialkylsilyl-indoles
UY28774A1 (es) Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes.
ATE539082T1 (de) Oxazinylisoflavonoidverbindungen, medikamente und anwendungen
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.